期刊文献+

基于JNK传导通路探析解毒通络调肝方调控内质网应激治疗2型糖尿病的实验研究 被引量:2

Experimental study on Jiedu Tongluo Tiaogan Formula to regulate and control endoplasmic reticulum stress in the treatment of type 2 diabetes: an exploration based on JNK signaling pathway
下载PDF
导出
摘要 观察解毒通络调肝方对肝脏JNK传导途径的影响。方法选用50只ZDF大鼠,饲养12周后48只成模,随机分组为模型组12只、二甲双胍组9只、解毒通络调肝方高、中、低剂量组各9只,ZL大鼠10只为空白对照组。模型组与空白组以蒸馏水,给药组给予相应药物,灌胃12周。定期对大鼠进行糖耐量实验,24周末切除肝脏,用于Western blot检测。结果与模型组比较,解毒通络调肝方高、中、低计量组和二甲双胍组各时点OGTT水平差异均有统计学意义(P<0.01);解毒通络调肝方高剂量与低剂量组比较,各时点差异均有统计学意义(P<0.05)。解毒通络调肝方高、中、低剂量组和二甲双胍组稳态葡萄糖输注率均较模型组提高,差异有统计学意义(P<0.01)。解毒通络调肝方高、中、低剂量组和二甲双胍组JNK及p-JNK表达量均较模型组下降,差异有统计学意义(P<0.01)。结论解毒通络调肝方改善治疗糖尿病可能的机制之一是抑制了JNK信号通路,降低了JNK磷酸化水平;糖毒性和胰岛素抵抗可能通过炎症激活JNK信号通路,增强JNK活性导致肝细胞损害。 Objective To observe the effect of Jiedu Tongluo Tiaogan Formula on liver JNK signaling pathway. Methods 50 ZDF rats were selected and fed for 12 weeks. Of them,48 rats were established into the models. They were randomly divided into the model group of 12 rats,metformin group of 9 rats,high-dose,moderate-dose and low-dose Jiedu Tongluo Tiaogan group of 9 rats each,blank control of 10 ZL rats. The model group and the blank group were given distilled water, drug taking group were given corresponding drugs by gavage for 12 weeks. Glucose tolerance test were made regularly. At the end of 24 th week,the rats' livers were removed for Western blot test. Results Compared with the model group,the difference of OGTT level at different time points in highdose,moderate-dose and low-dose Jiedu Tongluo Tiaogan Formula group and metformin group were statistically significant( P 0. 01);to compare high-dose and low-dose Jiedu Tongluo Tiaogan Formula, the difference of OGTT level at different time points were statistically significant( P 0. 05); steady state glucose infusion rate in high-dose,moderate-dose and low-dose Jiedu Tongluo Group and metformin group were increased compared with the model group,differences were statistically significant( P 0. 01). JNK and p-JNK expression in high-dose,moderate-dose and low-dose group and metformin group were lowered compared with the model group,the differences were statistically significant( P 0. 01). Conclusion One of the mechanisms of Jiedu Tongluo Tiaogan Formula to improve diabetes is to inhibit JNK signaling pathway,lower JNK phosphorylation level; glucose toxicity and insulin resistance may activate JNK signaling pathway and strengthen JNK activity which result in liver cell damage.
出处 《北京中医药》 2016年第6期567-569,576,共4页 Beijing Journal of Traditional Chinese Medicine
关键词 2型糖尿病 毒损肝络 解毒通络调肝方 JNK Type 2 diabetes mellitus damage of liver collaterals by toxicity Jiedu Tongluo Tiaogan Formula JNK
  • 相关文献

参考文献8

  • 1Muoio DM, Newgard CB. Biomedicine. Insulin resistancetakes a tri Pthrough the ER [ J ]. Science,2004,306(5695):425^61.
  • 2Hirosumi J,Tuncman G,Chang L,et al. A central roleforJNK in obesity and insulin resistance[ J]. Nature,2002,420(6913):333-336.
  • 3Pick A, Clark J, Kubstru PC, et al. Role of apoptosis infailure of beta-cell mass compensation for insulinresistance and beta-cell defects in the male Zuckerdiabetic fatty rat [ J]. Diabetes, 1998,47(3) :358-364.
  • 4Katsuragi I,Okeda T,Yoshimatsu H,et al. Transplantationof normal islets into the portal vein of Otsuka Long EvansTokushima Fatty rats prevents diabetic progression [J]. ExPBiol Med,2001,226(7) :681-685.
  • 5Shen N,Yu X,Pan FY, et al. An early responsetranscription factor, Egr-1, enhances insulinresistance intype 2 dia-betes with chronic hyperinsulinism[ J]. J BiolChem,2011,28 :14508-14515.
  • 6Boden G,Merali S. Measurement of the increase inendoplasmic reticulum stress-related proteins and genes inadipose tissue of obese,insulin-resistant individuals [ J ] .Methods Enzymol,2011,489:67-82.
  • 7王慧敏,都健.JNK信号转导通路与2型糖尿病[J].国际内科学杂志,2009,36(3):128-131. 被引量:12
  • 8Zhou Y,Lee J, Reno CM, et al. Regulation of glucosehomeostasis through a XBP-l-FoxOl interaction [ J ]. NatMed,2011,17:356-365.

二级参考文献22

  • 1Borsello T, Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des, 2007,13 ( 18 ) : 1875-1886.
  • 2Li Y,Batra S, Sassano A, et al. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type Ⅰ interferons. J Biol Chem,2006,281 (15) : 10651.
  • 3Abell AN, Granger DA, Johnson GL MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta. J Biol Chem J, 2007,282 ( 42 ) : 30476-30484.
  • 4Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw,2006,17 ( 1 ) :4-12.
  • 5Muniyappa H, Das KC . Activation of c-Jun N-terminal kinase (JNK) by widely used pecific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKKT-dependent mechanism. Cell Signal, 2008,20 (4) :675-683.
  • 6Hou N, Torri S, Saito N. Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p58 and c-Jun N-terminal kinase, and mitogen -activated protein kinase phosphatases. Endocrinology, 2008, 149 (4) : 1654-1665.
  • 7He T, Stepulak A, Holmstrom TH, et al. The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J Biol Chem, 2002, 277 ( 13 ) : 10767-10774.
  • 8Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinase. Science, 2002, 298:1911-1912.
  • 9Sharfi H, Eldar-Finkelman H. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling. Am J Physiol Endocrinol Metab, 2008, 294 (2) :E307- E315.
  • 10Nemazee D, Gavin A, Hoebe K, et al. Immunology: Toll- like receptors and antibody responses. Nature, 2006,441 (7091) :E4.

共引文献11

同被引文献24

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部